Click a link below to view the mailing archive as if it had been sent to you.
| 2020-09-30 12:15 | | 5 FDA approval decisions to watch in the 4th quarter and more... |
| 2020-09-30 00:15 | | Biogen's all-important Alzheimer's drug enters the review gauntlet and more... |
| 2020-09-29 12:15 | | Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J and more... |
| 2020-09-29 00:15 | | One year after Fetroja approval, Shionogi expands label to include difficult-to-treat pneumonia and more... |
| 2020-09-28 12:15 | | New document reveals scope and structure of Operation Warp Speed and underscores vast military involvement and more... |
| 2020-09-28 00:15 | | Fauci Sees Covid-19 Vaccines For Different Patients With Five In Final-Stage U.S. Trials and more... |
| 2020-09-27 00:15 | | U.S. appeals court rejects novel opioid settlement framework and more... |
| 2020-09-25 12:15 | | Another strong year for novel drug approvals is in the making and more... |
| 2020-09-25 00:15 | | Drugmakers push forward on large-scale production of coronavirus vaccines and more... |
| 2020-09-24 12:15 | | Here come the tortoises: In the race for a Covid-19 vaccine, slow starters could still win out and more... |
| 2020-09-24 00:15 | | FDA proposes change to rule on off-label drug use and more... |
| 2020-09-23 12:15 | | Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved and more... |
| 2020-09-23 00:15 | | Under fire, FDA Under fire, FDA to issue stricter guidance for Covid-19 vaccine EUA this week — reportF and more... |
| 2020-09-22 12:15 | | AstraZeneca’s Tagrisso Continues to Make Strides in Phase III Lung Cancer Trial and more... |
| 2020-09-22 00:15 | | Medicare May Not Cover Cost of Coronavirus Vaccine and more... |
| 2020-09-21 12:15 | | ESMO: Regeneron and Sanofi gun for Libtayo in first-line NSCLC with fresh survival stats and more... |
| 2020-09-21 00:15 | | ESMO: Roche’s Akt inhibitor scores slight win over J&J’s Zytiga and more... |
| 2020-09-20 00:15 | | ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial and more... |
| 2020-09-18 12:15 | | ESMO: Alkermes' major I-O hope sees progress across early cancer tests and more... |
| 2020-09-18 00:15 | | State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits” and more... |
| 2020-09-17 12:15 | | Moderna, in bid for transparency, discloses detailed plan of coronavirus vaccine trial and more... |
| 2020-09-17 00:15 | | Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters and more... |
| 2020-09-16 12:15 | | Lilly offers first evidence that its antibody drug may help treat COVID-19 and more... |
| 2020-09-16 00:15 | | Stem Cells May Help COVID-19 and ARDS Patients Breathe Easier and more... |
| 2020-09-15 12:15 | | Sanofi backs Escient's $77.5M round as it kick-starts first clinical test and more... |
| 2020-09-15 00:15 | | Marinus signs government contract worth up to $51M to advance drug candidate and more... |
| 2020-09-14 12:15 | | Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations and more... |
| 2020-09-14 00:15 | | Gilead to buy cancer drugmaker Immunomedics for $21B and more... |
| 2020-09-13 00:15 | | AstraZeneca, Oxford vaccine study allowed to restart in UK and more... |
| 2020-09-12 00:15 | | Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow |
| 2020-09-11 12:15 | | An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off and more... |
| 2020-09-11 00:15 | | Sanofi's hemophilia drug comes into focus as delays hit a key competitor and more... |
| 2020-09-10 12:15 | | FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD and more... |
| 2020-09-10 00:15 | | Medtronic Scores Breakthrough Designation for Transcatheter Tricuspid Valve and more... |
| 2020-09-09 12:15 | | Merck’s pneumonia vaccine posts two more hits and more... |
| 2020-09-09 00:15 | | Studies of AstraZeneca coronavirus vaccine put on hold for safety review and more... |
| 2020-09-08 12:15 | | COVID-19 vaccine CEOs vow to wait for phase 3 data before filing for approval and more... |
| 2020-09-07 00:15 | | FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures and more... |
| 2020-09-05 00:15 | | AbbVie puts $2B on the table for I-Mab cancer collab as biotech nabs $418M raise |
| 2020-09-04 12:15 | | Medtechs that book the most sales per employee face the greatest losses and more... |
| 2020-09-04 00:15 | | Is Abbott Making a Comeback in the Resorbable Stent Market? and more... |
| 2020-09-03 12:15 | | Sanofi, GSK, racing to catch up, begin their first human study of coronavirus vaccine and more... |
| 2020-09-03 00:15 | | CDC sets its sights on November COVID-19 vaccine deliveries: report and more... |
| 2020-09-02 12:15 | | Where Will Moderna Be in 1 Year? and more... |
| 2020-09-02 00:15 | | Bayer Agrees To Buy Personalized Vitamin Company Care/of At $225 Million Valuation and more... |
| 2020-09-01 12:15 | | In the footsteps of AstraZeneca, Novartis commits to carbon-neutral supply chain by 2030 and more... |
| 2020-09-01 00:15 | | Mylan yanks four lots of heart health, hemophilia injectables over packaging mix-up and more... |
